Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh Class A Liv...

Por Feiqian Wang, Feiqian Wang, Kazushi Numata, Satoshi Komiyama, Satoshi Komiyama, Haruo Miwa, Kazuya Sugimori, Katsuaki Ogushi, Satoshi Moriya, Akito Nozaki, Makoto Chuma, Litao Ruan, Shin Maeda
Publicado em 2022-05-01

A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma

Por Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Satoshi Moriya, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Shunji Hirose, Tatehiro Kagawa, Nobuhiro Hattori, Tsunamasa Watanabe, Kotaro Matsunaga, Michihiro Suzuki, Haruki Uojima, Hisashi Hidaka, Chika Kusano, Motoko Suzuki, Manabu Morimoto
Publicado em 2022-05-01